Vivos Therapeutics, Inc. (VVOS) Net Income by Year
Vivos Therapeutics, Inc. reported a net loss of $21.2M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $25.5M net loss. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Vivos Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VVOS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
VVOS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Vivos Therapeutics, Inc. financials
Frequently Asked Questions
What was Vivos Therapeutics, Inc.'s net income in fiscal year 2025?
Vivos Therapeutics, Inc. reported a net loss of $21.2M in fiscal year 2025.
How fast is Vivos Therapeutics, Inc.'s net income growing?
Vivos Therapeutics, Inc. (VVOS) reported a $11.1M net loss in fiscal year 2024 and a $21.2M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is Vivos Therapeutics, Inc.'s net income over the last twelve months?
Vivos Therapeutics, Inc. (VVOS) reported a $25.5M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Vivos Therapeutics, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Vivos Therapeutics, Inc. (VVOS) net income went from -$10.8M in fiscal year 2019 to -$21.2M in fiscal year 2025.
What was Vivos Therapeutics, Inc.'s net income in the most recent quarter?
Vivos Therapeutics, Inc. (VVOS) reported -$5.5M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Vivos Therapeutics, Inc. (VVOS) reported on that line in every period on record.